Resolve Biosciences is applying the power of Molecular Cartography™ to provide a single-molecule, high-resolution, highly multiplexed view of subcellular transcriptomic activity.
Location: Germany, Bavaria, Monheim
Employees: 51-200
Total raised: $71M
Founded date: 2020
Funding Rounds 1
Date | Series | Amount | Investors |
24.10.2022 | Series B | $71M | EDBI |
Mentions in press and media 6
Date | Title | Description |
06.01.2025 | PBS Biotech: $17 Million In Growth Capital Raised | PBS Biotech – a provider of single-use bioreactor systems and bioprocess development services – announced it secured $17 million in follow-on growth capital from Avego Management and BroadOak Capital Partners. These funds will advance PBS’ ... |
06.01.2025 | PBS Biotech Raises $17M in Growth Funding | PBS Biotech, a Camarillo, CA-based provider of single-use bioreactor systems and bioprocess development services, raised $17M in Growth funding. Backers included Avego Management, and BroadOak Capital Partners. The company intends to use th... |
05.01.2025 | The Aging Brain: Mapping the Path to Understanding and Treatment | The human brain is a marvel. It orchestrates our thoughts, emotions, and creativity. Yet, as the years pass, this intricate organ begins to falter. Memory fades. Concentration wanes. Learning becomes a steep hill to climb. Recent research s... |
04.01.2025 | Мозг под микроскопом: как стареют наши клетки и что с этим делать? | Человеческий мозг — удивительный и сложный орган, благодаря которому мы можем думать, чувствовать, творить и познавать мир. Но, к сожалению, с возрастом его работа постепенно ухудшается: получаемая извне информация забывается, нам труднее к... |
24.10.2022 | Resolve Biosciences Raises $71M in Series B Financing | Resolve Biosciences, a Monheim am Rhein, Germany-based molecular cartography technology company, raised $71m in Series B funding. The round was led by Patient Square Capital with participation from EDBI, PS Capital, Alafi Capital, and NRW.B... |
- | Resolve BioSciences | “Resolve Biosciences is applying the power of Molecular Cartography™ to provide a single-molecule, high-resolution, highly multiplexed view of subcellular transcriptomic activity.” |